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The transcription factor KLF2 regulates T cell traf-
ficking by promoting expression of the lipid-binding
receptor S1P1 and the selectin CD62L. Recently, it
was proposed that KLF2 also represses the expres-
sion of chemokine receptors. We confirmed the up-
regulation of the chemokine receptor CXCR3 on
KLF2-deficient T cells. However, we showed that
this was a cell-nonautonomous effect, as revealed
by CXCR3 upregulation on wild-type bystander cells
in mixed bone-marrow chimeras with KLF2-deficient
cells. Furthermore, KLF2-deficient T cells overpro-
duced IL-4, leading to the upregulation of CXCR3
through an IL-4-receptor- and eomesodermin-
dependent pathway. Consistent with the increased
IL-4 production, we found high concentrations of
serum IgE in mice with T cell-specific KLF2 defi-
ciency. Our findings support a model where KLF2
regulates T cell trafficking by direct regulation of
S1P1 and CD62L and restrains spontaneous cytokine
production in naive T cells.
INTRODUCTION
Kruppel-like factors (KLFs) are a family of zinc-finger transcrip-
tion factors that are expressed in a broad range of tissues and
at various times in ontogeny (Pearson et al., 2008). Germline
deletion of one of these factors, KLF2, is not compatible with
life because of vascular defects (Kuo et al., 1997a; Lee et al.,
2006). Studies done with KLF2 deficiency limited to only hema-
topoietic cells reported a striking loss of T cells from the blood,
lymph node, and spleen and grossly normal thymic development
(Kuo et al., 1997b).
Our laboratory previously reported an increase of mature CD4
and CD8 single positive (SP) cells in the KLF2-deficient thymus
(Carlson et al., 2006). KLF2-deficient SP thymocytes survived
in vitro and in vivo, so the lack of peripheral T cells is seemingly
not a result of cell death (Carlson et al., 2006; Sebzda et al.,
2008). Thus, the accumulation of mature SP cells in the thymus
implied an emigration defect. Consistent with this, KLF2-defi-
cient T cells showed severely reduced S1P1 expression (Carlson122 Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc.et al., 2006). S1P1 is a cell-surface receptor for the phospholipid
sphingosine-1-phosphate (S1P) and is required for thymic
emigration (Mandala et al., 2002; Matloubian et al., 2004).
KLF2 directly binds to the S1P1 promoter and induces S1P1 tran-
scription (Bai et al., 2007; Carlson et al., 2006). KLF2 also regu-
lates T cell expression of L-selectin (CD62L) (Bai et al., 2007;
Carlson et al., 2006; Dang et al., 2009; Sebzda et al., 2008).
Although CD62L is not required for thymic emigration, it is
required for entry into lymph nodes (Arbones et al., 1994), and
S1P1 is required for egress from lymph nodes (Matloubian
et al., 2004). Thus, KLF2 acts as a single transcription factor
controlling two key molecules—S1P1 and CD62L—required for
naive T cell trafficking through secondary lymphoid organs
(SLOs).
A recent report found that CD4+ T cells from KLF2-deficient
mice expressed multiple inflammatory chemokine receptors,
suggesting that loss of KLF2 leads to redirection of naive
T cells to nonlymphoid sites (Sebzda et al., 2008). Together,
these findings leave us with the appealing idea that KLF2 acts
as amaster regulator of naive T cell trafficking. KLF2would direct
naive T cells through SLOs by positively regulating CD62L and
S1P1 and would negatively regulate inflammatory chemokine
receptors to prevent naive T cells from entering nonlymphoid
tissues. However, in this report we demonstrated that expres-
sion of the inflammatory chemokine receptor CXCR3 in KLF2-
deficient T cells was regulated via a cell-nonautonomous
pathway. We found that KLF2-deficient T cells exhibited dysre-
gulated IL-4 production, which could act on bystander wild-
type T cells to induce aberrant expression of CXCR3. These
data suggest that KLF2 enforces naive T cell trafficking by
both autonomous and nonautonomous mechanisms. Further-
more, it suggests that KLF2 also maintains naive T cell identity
in terms of cytokine production because KLF2-deficient T cells
rapidly produce IL-4, a property usually associated with innate-
immune and memory T cells.
RESULTS
T Cell-specific KLF2 Deficiency Causes CXCR3
Upregulation
To further study how KLF2 regulates the expression of chemo-
kine receptors, we employed mice with a T cell-specific defi-
ciency in KLF2. We used CD4Cre mice crossed to mice with
KLF2 flanked by loxP sites (KLF2fl). In this model, the KLF2
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ment prior to the SP stage, where KLF2 is normally first
expressed. Such mice have a similar T cell phenotype to
KLF2-deficient fetal liver chimeras (Carlson et al., 2006) and to
VavCre-Klf2fl/fl mice (Sebzda et al., 2008). This includes severe
peripheral T cell lymphopenia and a 2-fold accumulation of
mature SP thymocytes (unpublished data).
We compared chemokine receptors on SP thymocytes puri-
fied from wild-type versus CD4Cre-Klf2fl/fl mice (here on referred
to as ‘‘Klf2/’’ mice). Althoughmost SP thymocytes are conven-
tional ab T cell precursors, this population normally also includes
low numbers of natural killer T (NKT) cells, gdT cells, Treg cells,
and recirculating memory T cells. We previously showed that
such unconventional T cells can complicate the analysis of SP
Figure 1. CXCR3 Is Upregulated on KLF2-Deficient SP Thymocytes
(A) Relative chemokine receptor gene expression from sorted wild-type and
CD4Cre/Klf2fl/fl (Klf2/) thymocytes. CD4 or CD8SP, TCRb+ cells were sorted
using a ‘‘dump strategy’’ to exclude CD25, TCRg, NK1.1, and CD1d-aGal-cer
tetramer-binding cells. RNA was prepared from cells of two independent sorts
from two animals and two littermate controls. Two independent cDNA prepa-
rations were made from each RNA sample. Graphs show the mean n-fold
difference ± standard deviation; n = 4.
(B) Flow-cytometry histograms of dump-negative CD4 or CD8SP thymo-
cytes. The black line indicates Klf2/, and the gray shaded histogram
indicates the wild-type. ‘‘nd’’ indicates not detected. Data in B are repre-
sentative of independent analysis from at least three animals of each geno-
type.thymocytes (McCaughtry et al., 2007). To focus our analysis on
conventional ab T cells, we used a ‘‘dump strategy’’ to exclude
cells that expressed CD25, TCRg, NK1.1 or were capable of
binding CD1d-aGal-cer tetramers. We observed a striking over-
expression of CXCR3 mRNA in KLF2-deficient conventional
thymocytes (Figure 1A); this expression was 10-fold higher for
CD4SP thymocytes and 40-fold higher for CD8SP thymocytes
than for wild-type cells. CXCR3 protein expression was
confirmed by flow cytometry and was observed both on thymo-
cytes (Figure 1B) and peripheral T cells (data not shown). CXCR3
is typically not expressed on naive cells but can be upregulated
on effector and memory T cells. It has three ligands, CXCL9,
CXCL10, and CXCL11, which are produced at sites of inflamma-
tion. In contrast to the findings of a previous publication (Sebzda
et al., 2008), we did not observe upregulation of any other inflam-
matory chemokine receptor mRNA (Figure 1A), nor could we
confirm protein upregulation for CCR3, CCR5, or CCR6
(Figure 1B and unpublished data). Although we cannot fully
explain the discrepancies at this time, there are two key differ-
ences between the studies. First, Sebzda et al. used vavCre,
whereas we used CD4Cre to delete KLF2. The other is our use
of the dump strategy to exclude unconventional T cells because
such cells are dysregulated in KLF2-deficient mice (Figure S1).
Nonetheless, the CXCR3 protein was clearly upregulated on
conventional ab T cells from CD4Cre-Klf2fl/fl mice.
CXCR3 Is Indirectly Regulated in KLF2-Deficient Mice
During our study of CXCR3 on KLF2-deficient T cells, we noticed
variation in the expression of CXCR3. In particular, CD8 T cells
often expressed more CXCR3 than CD4 T cells, and the
percentage of KLF2-deficient T cells expressing CXCR3
increased with age. In contrast, direct KLF2 targets—CD62L
and S1P1—were consistently downregulated in KLF2-deficient
T cells, independently of age (data not shown). We hypothesized
that an altered thymic environment induced by KLF2 deficiency
might lead to the increased CXCR3. To investigate the possibility
of a bystander effect caused by KLF2-deficient cells, we set
up mixed bone-marrow chimeras in which KLF2-deficient
progenitors were a majority and wild-type cells were a minority
(Figure 2A). We used allelic markers, Thy1.1 and CD45.2, to
distinguish donor populations from each other and from host
cells. After gating was performed on CD4SP thymocytes from
such chimeras, CD62L expression was reduced only in KLF2-
deficient cells (upper left panel Figure 2B) and not in wild-type
progenitors (upper right panel Figure 2B), confirming direct
regulation by KLF2. As expected, CXCR3 was upregulated on
KLF2-deficient thymocytes, and in chimeras of this age the
CXCR3 upregulation was more striking on CD8SP thymocytes
than on CD4SP thymocytes (lower left panels Figure 2B). Clearly,
CXCR3 was also expressed on wild-type thymocytes in the
predominantly KLF2-deficient thymus (lower right panels
Figure 2B), again more so on CD8SP thymocytes than CD4SP
thymocytes. The expression of CXCR3 on wild-type cells indi-
cates that KLF2 deficiency in T cells leads to cell extrinsic upre-
gulation of CXCR3 on bystander cells.
It is still be possible that CXCR3 might be both directly and
indirectly regulated by KLF2. However, in chimeras in which
wild-type cells predominate, KLF2-deficient thymocytes did
not express any detectable CXCR3 (Figure S2), suggestingImmunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc. 123
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regulated at themRNA level in the wild-type bystander cells from
the KLF2-deficient environment (Figure 2C). In contrast, S1P1
mRNA expression was significantly lower in KLF2-deficient
T cells than in wild-type bystander cells (Figure 2C), confirming
direct regulation by KLF2. Thus, it would appear that KLF2
does not directly repress chemokine receptors, but its deficiency
leads to upregulation of CXCR3 on bystander cells.
KLF2 and CXCR3 Are Coexpressed
in Memory Phenotype Cells In Vivo
The hypothesis that KLF2 directly represses CXCR3 predicts
that KLF2 and CXCR3 would not be mutually expressed
in vivo. However, our findings suggest instead that KLF2-defi-
ciency has an indirect effect on CXCR3 expression. To explore
this concept further, we sought to assess the expression of
KLF2 and CXCR3 in individual T cells, but the lack of detection
Figure 2. CXCR3 Is Expressed onWild-Type
Thymocytes in a KLF2-Deficient Environ-
ment
Mixed bone-marrow chimeras were created by
mixing bone marrow from Thy1.1+/CD45.2+ wild-
type mice with that from Thy1.2+/CD45.2+ Klf2/
mice at unequal ratios and reconstituting CD45.1+
lethally irradiated recipients.
(A) Schematic for unequal mixed bone-marrow
chimera set-up.
(B) Flow cytometry for surface expression of
CD62L and CXCR3 on dump-negative CD4 or
CD8SP thymocytes, as defined in Figure 1 and
gated as indicated. The observed chimerism ratio
in SP thymocytes for these particular 8-week-
post-transplant animals is shown. Similar results
were observed in more than ten chimeric animals
in multiple experiments.
(C) Single positive thymocytes were sorted from
wild-type (Thy1.1+) cells from a wild-type thymus
(left bar), wild-type (Thy1.1+) cells from a KLF2-
deficient majority mixed-chimera thymus (middle
bar), or KLF2-deficient cells from a KLF2-deficient
thymus (right bar). All values are shown relative
to the value from wild-type cells sorted on the
same day. Graph is of the mean ± SD of four
PCR experiments and two separate sorts. y axis
is on a logarithmic scale. ‘‘nd’’ indicates not
detected. # indicates detection in only one PCR
reaction. *p < 0.05, **p < 0.0001.
of KLF2 by flow cytometry with commer-
cially available antibodies did not allow
these studies. To overcome this ob-
stacle, we generated knock-in mice
where GFP was inserted in-frame at the
KLF2 translational start site in exon 1
and thus created a GFP-KLF2 fusion
protein (Figure S3A). The fact that homo-
zygous Klf2GFP reporter mice are viable
and have normal numbers of CD4+ and
CD8 T+ cells (Figure S3B) implies that
the GFP-KLF2 fusion protein is func-
tional, which is in contrast to the embryo-
logical lethality of Klf2/mice. Furthermore, these mice appear
to be faithful reporters of KLF2 expression: GFP was not ex-
pressed until the mature (Qa2 hi, CD69 low) stage of SP thymo-
cyte development (Figures S3C–S3F), consistent with what was
previously reported for mRNA analysis (McCaughtry et al., 2007).
Because thymocytes do not normally express CXCR3, we
examined KLF2 and CXCR3 expression in peripheral T cells.
Interestingly, memory T cells (CD44hi) showed heterogeneity in
KLF2 expression (Figure 3), consistent with the fact that KLF2
is downregulated during T cell activation but can be upregulated
again (Schober et al., 1999). In these memory phenotype cells,
CD69 and KLF2 (GFP) were inversely correlated (Figure 3,middle
panels). This is consistent with the CD69 upregulation observed
on KLF2-deficient T cells (Carlson et al., 2006) because CD69
and S1P1 have been show to antagonize each other on the cell
surface (Shiow et al., 2006). Thus, the inverse correlation
between CD69 and KLF2 could represent a positive correlation124 Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc.
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found that S1P1 surface expression was limited to KLF2-ex-
pressing (GFP+) thymocytes (Figure S3G). In addition, we found
that S1P1 mRNA expression was more than 40-fold higher in
GFP+ than in GFP thymocytes (unpublished data). An inverse
correlation would also be expected if KLF2 directly repressed
chemokine receptors, such as CXCR3. However, there was no
correlation between KLF2 (GFP) expression and CXCR3 in either
CD4 or CD8 memory phenotype T cells (Figure 3, bottom panel).
Thus, our data do not support direct repression of chemokine
receptors by KLF2.
Thymic Retention and Peripheral Lymphopenia
Are Cell Intrinsic
Despite the fact that KLF2 did not directly regulate chemokine
receptors, it is possible that the cell-nonautonomous upregula-
tion of CXCR3 in KLF2-deficient mice could be responsible for
lymphopenia by sequestering T cells in nonlymphoid organs. If
peripheral lymphopenia were solely due to inappropriate chemo-
kine receptor expression, then we would expect that CXCR3-ex-
pressing wild-type T cells in mixed bone-marrow chimeras
would also be reduced in the periphery. Alternatively, if lympho-
penia were due to cell-autonomous gene regulation in KLF2-
deficient thymocytes (for example reduced S1P1), we would
expect KLF2-deficient T cells to be preferentially absent in the
Figure 3. A KLF2-GFP Reporter Mouse Shows No Correlation
between KLF2 and CXCR3 in CD4 or CD8 Memory T Cells
Top panel: CD44 expression on dump-negative CD4 and CD8 T cells from
spleen of KLF2-GFP reporter mice (see Figure S2). Middle and bottom panels
show flow-cytometry dot plots from the gated CD44hi ‘‘memory phenotype’’
CD4 (left) and CD8 (right) populations. Similar results were observed in two
other KLF2-GFP reporter miceperiphery. To answer this question, we analyzed recent thymic
emigrants (RTEs) in mixed bone-marrow chimeras. For this anal-
ysis, a covalent label is injected directly into the thymus, and
peripheral tissues are evaluated 2 days later for cells bearing
the label. This approach not only allows analysis of cells with
and without KLF2 in the same animal, but it also eliminates vari-
ability due to differential marking from the intrathymic injections.
KLF2 is not expressed until the SP stage in thymocyte develop-
ment, so we standardized each chimeric animal to the ratio of
Klf2/ to wild-type in the DP population. The ratio of Klf2/
to wild-type cells increased from 1 in DP thymocytes to approx-
imately 2 in SP thymocytes, consistent with an increased reten-
tion of mature KLF2-deficient thymocytes (Figure 4 and [Carlson
et al., 2006]). In contrast, the Klf2/ KO:wild-type ratio dramat-
ically decreased in CD4 and CD8 RTEs in peripheral lymphoid
organs, indicating a strong preferential emigration of wild-type
cells. We found that wild-type RTEs predominated in the liver
as well, arguing against the idea that KLF2-deficient T cells exit
the thymus normally but are preferentially sequestered in non-
lymphoid tissue (Sebzda et al., 2008). Thus, our data support a
model of cell-intrinsic lymphopenia, largely due to impaired
emigration from the thymus, in KLF2-deficient mice.
KLF2-Deficient T Cells Overproduce IL-4
We next wanted to define the molecular mechanism for the cell-
nonautonomous upregulation of CXCR3 in the presence of Klf2/
T cells. Because KLF2-deficient thymocytes were retained in the
thymic medulla, one possibility is that ‘‘thymic crowding’’ could
create a situation in which CXCR3 is upregulated. Therefore,
we examined S1P1-deficient thymocytes, which have a similar
thymic emigration defect and retention of mature SP thymocytes
Figure 4. KLF2-Deficient Cells Are Defective in Thymic Emigration
Recent thymic emigrants (RTEs) were measured in mixed bone-marrow
chimeras by analysis of peripheral tissues 48 hr after intrathymic injection of
a biotinylating agent. The graph displays the ratio of KLF2-deficient cells to
wild-type cells in various populations. To allow comparison between different
experiments, we normalized the ratio in DP to one. Thus, a ratio greater than
one signifies an increase in KLF2-deficient cells relative to wild-type cells,
and less than one means there are relatively more wild-type cells. Error bars
indicate the standard deviation. n = 8 chimeras for LN and spleen, and n = 3
for liver. *p < 0.05, **p < 0.001.Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc. 125
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S1P1-deficient thymi had an increased proportion of mature
(HSA-low) SP thymocytes. However, only KLF2-deficient SP
cells expressed increased CXCR3 (unpublished data). Thus, it
is unlikely that cell-nonautonomous effects are due to ‘‘thymic
crowding.’’
Another possible mechanism is that KLF2-deficient cells might
secrete a factor into the thymic environment and that this factor
might cause the cell-nonautonomous effect. We found that
KLF2-deficient CD4SP thymocytes express more IL-4 mRNA
than wild-type thymocytes by real-time PCR (Figure 5A). To
determine whether KLF2-deficient thymocytes had the ability to
produce IL-4 protein, we stimulated KLF2-deficient and wild-
type thymocytes directly ex vivo with phorbol 12-myristate 13-
acetate (PMA) and ionomycin. Significantly more KLF2-deficient
CD4 and CD8SPs produced IL-4 under these conditions






Figure 5. Bystander Upregulation of CXCR3
Is Dependent on the IL-4 Receptor
(A) Quantitative RT PCR analysis of IL-4 mRNA
from sorted dump-negative CD4SP thymocytes
from wild-type and Klf2/ mice. Graph is of the
mean ± SDof four PCR experiments and two sepa-
rate sorts.
(B) Thymocytes were stimulated ex vivo with PMA
and ionomycin for 5 hr, and then intracellular stain-
ing was done for IL-4. Dump-negative CD4SP and
CD8SP are shown in the dot plots. The bar graph
on the right shows the average percent of IL-4
secretion from four paired sets of animals in one
experiment. The experiment was repeated three
times with similar results. *p < 0.05. Error bars indi-
cate standard deviation.
(C) Flow-cytometry histograms of CD124 surface
expression on SP thymocytes from mixed
chimeras, gated as in Figure 2B.
(D) Serum was collected from mice 40–100 days
old., and IgE concentrations were determined.
wild-type: n = 12, Klf2/: n = 22. Error bars indi-
cate standard deviation.
(E) Flow cytometry from the indicated mixed
chimeras for surface expression of CXCR3 on
dump-negative SP thymocytes. Data are repre-
sentative of more than five experiments. Percent-
ages indicate the proportion in the dump-negative
CD4SP gate.
(F) CXCR3 and CCR3 expression on mature
(Qa-2hi) CD8SP thymocytes after 4 days of
in vitro culture with IL-7 (filled gray) or IL-4 (black
line). Results were representative of five indepen-
dent experiments.
Treg cells, were excluded from this
analysis. Because NKT cells are known
to rapidly produce IL-4, we created
CD4Cre-Klf2fl/fl-Cd1d/ mice to test
whether invariant NKT cells were the
source (Smiley et al., 1997). We observed
the upregulation of CXCR3 on KLF2-defi-
cient SP thymocytes in the presence and
absence of invariant NKT cells
(Figure S4). This suggests that KLF2 deficiency increases the
potential for rapid IL-4 production in conventional T cells.
To determinewhethermore IL-4 is produced in vivo aswell, we
analyzed the expression of IL-4 receptor a (CD124) because IL-4
signaling leads to increased surface expression of CD124 (Ohara
and Paul, 1988). CD124 expression was modestly, but consis-
tently, upregulated on thymocytes from KLF2-deficient mice
(unpublished data). This was also the case for both bystander
wild-type and KLF2-deficient thymocytes in mixed chimeras in
which KLF2-deficient cells were the majority (Figure 5C).
Because IL-4 is amajor regulator of Th2 cell differentiation (Ansel
et al., 2006), we looked for systemic effects of increased IL-4 by
analysis of serum IgE, a classical type 2 antibody (Coffman et al.,
1986). KLF2-deficient mice had a striking 33-fold increase in
serum IgE compared to age-matched controls (Figure 5D). To
distinguish a specific IgE upregulation from broad hypergamma-
globulinemia, we assayed a broader range of isotypes. IgM, IgA,126 Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc.
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versus KLF2-deficient mice. IgG1 was significantly but more
modestly upregulated in comparison to IgE (Figure S5). This is
consistentwith IL-4’sknownrole in inducing IgEand IgG1 (Snapper
and Paul, 1987). Thus, T cell-specific KLF2 deficiency leads to
elevated IL-4 in vivo and systemically elevated IgE in the serum.
To test whether CXCR3 expression in the KLF2-deficient
thymus was dependent on IL-4 responsiveness, we generated
mixed chimeras in which the majority were KLF2-deficient
progenitors and the minority were either wild-type or IL-4Ra
deficient. Again, wild-type bystander cells in the KLF2-deficient
environment expressed CXCR3. However, Il4ra/ bystander
cells did not show CXCR3 upregulation, suggesting that they
are resistant to this bystander effect (Figure 5E, right panels).
Importantly, the KLF2-deficient cells from the same thymus as
the Il4ra/ cells did express CXCR3 (Figure 5E, left panels).
This indicates that CXCR3 induction is strictly dependent on IL-4.
IL-4Ra can pair with either the common g chain to produce the
type I IL-4 receptor or the IL-13 receptor for the type II receptor
(Ramalingam et al., 2008). In mixed chimeras, IL-13R-deficient
bystander cells in a KLF2-deficient thymus still upregulated
CXCR3 (Figure S6), suggesting that type II IL-4 receptors are
dispensable. Hence, taken together, these data suggest the
type I IL-4 receptor (IL-4Ra and common g chain) is required
for bystander T cell upregulation of CXCR3.
From past work, it was shown that CXCR3 is primarily induced
during Th1 cell responses, yet IL-4 skews T cells toward a type 2
Figure 6. CXCR3 Upregulation Is Dependent on Eomesodermin
(A) Quantitative RT PCR on RNA from sorted dump-negative CD4SP and
CD8SP thymocytes from wild-type and intact KLF2-deficient mice. Displayed
is KLF2-deficient mRNA expression relative to wild-type expression. Graphs
represent the mean ± SD of four PCR experiments and two separate sorts.
(B) Flow cytometry from indicated mixed chimeras for surface expression of
CXCR3 on dump-negative SP thymocytes. Results are representative of three
experiments.response (Zhu and Paul, 2008). Thus our finding of CXCR3 upre-
gulation due to IL-4 was unexpected. However, the paradigm of
CXCR3 association with Th1 cell cytokines was established in
activated CD4 T cells, and in our model CXCR3 is expressed
most strongly on naive CD8 thymocytes. Hence, we directly
tested the impact of IL-4 on CXCR3 expression in naive CD8
T cells. Interestingly, in vitro culture of thymocytes and spleno-
cytes showed that IL-4 (with or without IL-7), but not IL-7 alone,
induced expression of CXCR3 but not CCR3 on CD8SP thymo-
cytes and mature T cells (Figure 5F and unpublished data). Thus,
we propose that KLF2-deficient T cells spontaneously produce
IL-4 and that this cytokine efficiently upregulates CXCR3 expres-
sion on both wild-type and KLF2-deficient naive CD8 T cells.
CXCR3 Upregulation Requires Eomesodermin
CXCR3 expression in T cells is dependent on the presence of at
least one of the T box transcription factors eomesodermin
(Eomes) and T-bet (Intlekofer et al., 2008; Lord et al., 2005).
We showed that both KLF2-deficient CD4 and CD8SPs have
higher expression of Eomes mRNA than wild-type SPs by real-
time PCR (Figure 6A). Although Eomes was overexpressed, the
highly homologous transcription factor T-bet was not
(Figure 6A). Previous studies showed that IL-4 can induce Eomes
in antigen-stimulated CD8-T cells in vitro (Takemoto et al., 2006).
Thus, we wished to determine whether Eomes was required for
the bystander CXCR3 upregulation in KLF2-deficient mice.
A T cell-specific Eomes-deficient mouse strain has recently
been described (Intlekofer et al., 2008), and these animals
display normal thymic development. To probe the role of Eomes
in bystander CXCR3 induction, we again generated mixed
chimeras comprising a majority of KLF2-deficient cells with
a minority of wild-type or CD4-Cre Eomesfl/fl bone marrow.
When KLF2-deficient thymocytes were the majority, they ex-
pressed CXCR3 (Figure 6B, left panels). As expected, wild-
type bystander cells expressed CXCR3, but Eomes-deficient
bystander cells did not upregulate CXCR3 (Figure 6B, right
panels). These data suggest that Eomes is essential for the
induction of CXCR3 in the bystander T cell population.
Together, these data suggest a model for CXCR3 upregulation
in the KLF2-deficient thymus, as summarized in Figure S7. KLF2-
deficient thymocytes overproduce IL-4, which signals via the
type I IL-4R pathway and the transcription factor eomesodermin
to upregulate CXCR3 in a cell-nonautonomous fashion.
DISCUSSION
Our data provide compelling evidence for a cell-nonautonomous
or bystander effect leading to chemokine receptor upregulation
in the KLF2-deficient thymus. There is precedence for cell non-
autonomy in many gene-deficient mouse models (Whyatt and
Grosveld, 2002) and in C. elegans (Apfeld and Kenyon, 1998).
Cell-nonautonomous effects have been previously observed in
the thymus as well (Schnell et al., 2006). When tissue-specific
promoters are used to direct gene deficiency to one cell type
and effects are observed on another cell type, it is easy to
conclude that cell-nonautonomous effects are involved. In our
case, however, T cell-specific gene deletion caused cell-nonau-
tonomous effects on other T cells, which could only be revealedImmunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc. 127
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deleted cells were present in the same population.
The paucity of KLF2-deficient T cells in SLOs and blood has
been a consistent finding in all studied models, and published
studies agree that KLF2 regulates multiple factors that are
important for T cell migration. But whatmolecules normally regu-
lated by KLF2 cause the peripheral lymphopenia? Sebdza and
colleagues suggested that KLF2 deficiency derepressesmultiple
chemokine receptors and thus leads to tissue localization of
T cells (Sebzda et al., 2008). We think this is unlikely to account
for the lymphopenic phenotype for several reasons. First, the
lack of S1P1 is profound.Wewere unable to detect S1P1 staining
above background on CD4SP or CD8SP thymocytes. KLF2 and
S1P1 T cell deficiency cause a similar accumulation of mature
thymocytes (Carlson et al., 2006; Matloubian et al., 2004). In
both cases, there is a significant (2-fold) increase in the number
of mature SP thymocytes, which is inconsistent with normal
thymocyte emigration. One distinction is the CD62Lhi phenotype
of T cells with S1P1 deficiency, whereas KLF2-deficient T cells
have low CD62L (Matloubian et al., 2004). The lack of CD62L
on KLF2-deficient T cells is consistent with direct regulation by
KLF2 (Bai et al., 2007; Dang et al., 2009). Because CD62L is
necessary for lymph node entry (Arbones et al., 1994), this also
explains differences in trafficking between KLF2 and S1P1-defi-
cient T cells when they are adoptively transferred into the blood
(Carlson et al., 2006;Matloubian et al., 2004). Second, we did not
observe preferential homing of KLF2-deficient T cells to the liver,
in contrast to Sebzda et al. Finally, we observed the upregulation
of only one chemokine receptor (CXCR3) rather than the increase
in ten chemokine receptors as observed by Sebzda et al. These
differences may all relate to the model systems used. Sebzda
et al. induced Klf2 deletion via Cre driven by the Vav promoter
(Sebzda et al., 2008), which is expressed in all hematopoietic
cells (Stadtfeld and Graf, 2005), whereas our system (using
CD4Cre) has expression limited to the T cell lineage (Lee et al.,
2001). Furthermore, our analysis was focused on ‘‘conventional’’
T cells, and we excluded cells expressing CD25, TCRg, and
NK1.1 and those capable of binding CD1d/aGal-cer tetramers.
We are currently exploring the role of KLF2 in the homeostasis
and migration of nonconventional T cell subsets to address
this point further.
Although our findings do not support a model in which KLF2
directly represses chemokine receptors, they led us to discover
a novel function for KLF2: the cell-intrinsic suppression of IL-4 in
T cells. KLF2-deficient thymocytes had increased amounts of
IL-4 mRNA and were able to rapidly produce the cytokine
upon stimulation ex vivo. An elevated serum IgE concentration
suggested that IL-4 is overproduced in vivo as well. NKT cells
are major, rapid producers of IL-4. One possibility for the
increased IL-4 in the KLF2-deficient thymus is dysregulated
homeostasis, trafficking, and/or activation of NKT cells. To
address this, we generated CD4Cre-Klf2fl/fl-Cd1d/ mice, in
which deletion of CD1d drastically reduces the number of NKT
cells (Smiley et al., 1997). The thymocytes from these mice still
had increased expression of both CXCR3 and CD124, indicating
that IL-4 continued to be overproduced. This suggests that
invariant NKT cells are not the sole provider of spontaneous
IL-4 and the bystander effect in this model. Whether the effect
of KLF2 is direct or indirect in regulating the IL-4 locus is currently128 Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc.unclear. IFNg and TNFa were also overproduced by KLF2-defi-
cient T cells (unpublished data). Thus, it is interesting to note
that KLF2-deficient T cells exhibit some functions similar to
‘‘innate immune’’ T cells.
Finally, our data showed that the IL-4 effect onCXCR3 upregu-
lation required the transcription factor Eomes. Eomes or the
related T box transcription factor T-bet was required for
CXCR3 upregulation in T cells in other contexts (Intlekofer
et al., 2008; Lord et al., 2005). A role for IL-4 in inducing
CXCR3 seems counterintuitive, given that CXCR3 expression
is typically associated with a Th1-type IFNg-dependent
response. Nevertheless, our results are consistent with previous
studies, which showed that IL-4 can induce Eomes in antigen-
stimulated CD8-T cells (Takemoto et al., 2006).
Overall, our findings suggest that KLF2 is an important tran-
scriptional regulator of naive T cell identity in that it promotes
the ability of T cells to recirculate through secondary lymphoid
organs, whereas at the same time it represses rapid cytokine
production in the T cell pool.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6.SJL-Ptprca Pepcb (CD45.1 congenic B6) mice were
purchased from the National Cancer Institute. B6.PL-Thy1a (CD90.1 congenic
B6) and BALB/c-Il4ratm1Sz (IL-4 receptor KO) mice were purchased from Jack-
son Labs. C57BL/6NTac-Tg(CD4Cre) (Lee et al., 2001) were obtained from
Taconic farms. Klf2fl mice were created in Jerry Lingrel’s laboratory at the
University of Cincinnati. In brief, loxP sites were inserted into introns 1 and 2
of the Klf2 allele. The Klf2 floxed mice were generated in Duffy ES cells
(129SvEv/Tac) and backcrossed to the B6 strain for a minimum of five gener-
ations before being crossed with CD4Cre mice (Jerry Lingrel, personal
communication). Ingenious Targeting Labs generated the KLF2GFP reporter
mice according to the strategy in Figure S3A by using C57BL/6 ES cells.
OT-I mice (C57BL/6 TCR transgenic strain specific for OVA257-263/K
b [Hog-
quist et al., 1994]) were maintained in our facility. All animal experimentation
was approved by the University of Minnesota IACUC committee.
Mixed Bone-Marrow Chimera
We generated mixed bone-marrow chimeras by mixing T cell-depleted bone
marrow preparations from Thy1-distinct, CD45.2+ strains at various ratios
and injecting 5 3 106 to 10 3 106 total cells into lethally irradiated (1000
rads) CD45.1+ host animals. For chimeras with Eomes-deficient and IL-13R-
deficient bone marrow, femurs and tibias were shipped overnight on wet ice
in RPMI + 10%FCS fromSteve Reiner’s laboratory (University of Pennsylvania)
and Thomas Wynn’s laboratory (NIAID), respectively. For chimeras with IL-4R
KO bonemarrow, we treated the recipients with 50 mg NK1.1 specific antibody
(clone PK136) intraperiotinally one day prior to the marrow transplant and then
with 25 mg on days 7 and 14 after themarrow transplant to deplete NK cells and
prevent graft rejection because the IL-4R KO and control marrow were of
BALB/c origin and the recipients were C57BL/6 3 BALB/c F1 mice. All
chimeras were analyzed 8–12 weeks after the transplant. Single-cell suspen-
sions of thymus, lymph node, and spleen were stained with fluorescence-
activated cell sorting (FACS) antibodies and analyzed by flow cytometry.
Flow Cytometry
Single-cell suspensions from spleen, lymph nodes, or thymus were prepared.
We incubated biotinylated CD1d-aGalCer monomers (NIH tetramer facility)
with Streptavidin-PE or Streptavidin-APC at 4C overnight to create fluores-
cent multimers. Cells were analyzed on a Becton Dickinson LSR II instrument,
and the data were processed with FlowJo (Tree Star) software. Antibodies to
standardmouse lymphocyte surface antigenswere purchased fromBiolegend
(San Diego, CA) or eBioscience (San Diego, CA). In addition, antibodies to
CXCR3-PE (R&D Systems, Minneapolis, MN), CCR3-AF647, CCR5-biotin,
and CD124-biotin (all from BD PharMingen, San Diego, CA), were used. A
Immunity
KLF2 Restrains Naive T Cell Identitypolyclonal antibody to S1P1was the kind gift of Jason Cyster (University of Cal-
ifornia, San Francisco) and has been described previously (Lo et al., 2005). For
detection, anti-rabbit IgG biotin (BD PharMingen) and then Streptavidin-APC
(Invitrogen, Carlsbad, CA) were used.
Cell Sorting and Real-Time RT-PCR
We used fluorescence-activated cell sorting to purify ‘‘dump’’-negative
CD4SP and CD8SP thymocytes. To purify the minority population from mixed
chimeras, we depleted the majority population via negative selection with anti-
CD90.2 microbeads by using MACS separation columns (Miltenyi Biotech,
Bergisch Gladbach, Germany). Sorting was performed on a FACSAria (Becton
Dickinson) and was reliably > 90% of the target population. RNA was isolated
from sorted populations with the RNeasy kit (QIAGEN, Valencia, CA), and
cDNA was produced with the SuperScriptIII Platinum Two-Step qRT-PCR kit
(Invitrogen), PCR products were amplified with the Fast Start SYBR Green
Master mix (Roche, Basel, Switzerland) and detected with a SmartCycler
(Cepheid, Sunnyvale, CA). We used hypoxanthine-guanine phosphoribosyl
transferase (HPRT) to normalize samples. Each group was sorted in at least
two independent experiments, and cDNA was prepared twice from each sort.
Primers were designed with the Ensembl database and Primer3. Primers are
published in the Supplemental Data.
Quantification of RTEs
Sedated mice were intrathymically injected with up to 10 ml/lobe of 5 mg/ml
sulfo-NHS-LC biotin from Pierce Chemical Co. (Rockford, IL) in PBS. Thymus,
lymph node, spleen, and liver were harvested 48 hr later, stained with fluores-
cently conjugated streptavidin and other antibodies, and analyzed by flow cy-
tometry. Routinely performed analysis of streptavidin binding on splenic B
cells ensured that covalent labeling was restricted to the thymus.
In Vitro IL-4 Production
Thymocytes were isolated and plated at 13 106 cells/ml. The cells were stim-
ulated with 50 ng/ml PMA and 1.5 mM ionomycin (Sigma-Aldrich, St. Louis,
MO) for five hours with GolgiStop Protein Transport Inhibitor (BD PharMingen)
added for the final three hours. The cells were surface stained and then stained
with anti-IL-4 (11B11) (eBioscience) via a fix/perm kit (BD PharMingen) and
analyzed by flow cytometry.
Serum IgE
A mouse IgE ELISA MAX kit (Biolegend) was used for quantifying IgE from
serum samples. Samples were run in duplicate.
In Vitro Cytokine Stimulation
Splenocytes and thymocytes were cultured (1 3 106 splenocytes/ml, 5 3 106
thymocytes/ml) with IL-7 (10 ng/ml), IL-4 (20 ng/ml), or both for 4 days. Cells
were analyzed by flow cytometry with an anti-CXCR3-PE (220803) antibody.
Cytokines and antibody were purchased from R&D Systems.
Statistical Analysis
Statistical analysis was performed with Prism (Graphpad software), unpaired t
tests were used for IgE data, and paired t tests were used for RT PCR and
normalized RTE analysis.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found at http://www.cell.
com/immunity/supplemental/S1074-7613(09)00279-9.
ACKNOWLEDGMENTS
The authors wish to thank Caitlin Dejong for preparing and shipping Eomes-
deficient bones and Thirumalai Ramalingam and Thomas Wynn for providing
IL-13R-deficient bones. Jerry Lingrel provided Klf2fl mice. Jason Cyster
provided reagents and assistance with anti-S1P1 staining. Xiao Jie Ding and
Jason Vevea provided excellent technical support. We thank Oludare
Odumade and Amy Moran for helpful discussion and critical review of the
manuscript. The authors declare no competing financial interests. Thisresearch was supported by NIH grants R01-AI39560 (to K.A.H.), R01-
AI38903 (to S.C.J.), and T32-AI007313 (to M.A.W.).
Received: February 24, 2009
Revised: April 27, 2009
Accepted: May 12, 2009
Published online: July 9, 2009
REFERENCES
Allende, M.L., Dreier, J.L., Mandala, S., and Proia, R.L. (2004). Expression of
the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic
emigration. J. Biol. Chem. 279, 15396–15401.
Ansel, K.M., Djuretic, I., Tanasa, B., and Rao, A. (2006). Regulation of Th2
differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24, 607–656.
Apfeld, J., and Kenyon, C. (1998). Cell nonautonomy of C. elegans daf-2 func-
tion in the regulation of diapause and life span. Cell 95, 199–210.
Arbones, M.L., Ord, D.C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G.,
Capon, D.J., and Tedder, T.F. (1994). Lymphocyte homing and leukocyte
rolling and migration are impaired in L-selectin-deficient mice. Immunity 1,
247–260.
Bai, A., Hu, H., Yeung, M., and Chen, J. (2007). Kruppel-like factor 2 controls
T cell trafficking by activating L-selectin (CD62L) and Sphingosine-1-phos-
phate receptor 1 transcription. J. Immunol. 178, 7632–7639.
Carlson, C.M., Endrizzi, B.T., Wu, J., Ding, X., Weinreich, M.A., Walsh, E.R.,
Wani, M.A., Lingrel, J.B., Hogquist, K.A., and Jameson, S.C. (2006). Krup-
pel-like factor 2 regulates thymocyte and T-cell migration. Nature 442, 299–
302.
Coffman, R.L., Ohara, J., Bond, M.W., Carty, J., Zlotnik, A., and Paul, W.E.
(1986). B cell stimulatory factor-1 enhances the IgE response of lipopolysac-
charide-activated B cells. J. Immunol. 136, 4538–4541.
Dang, X., Raffler, N.A., and Ley, K. (2009). Transcriptional regulation of mouse
l-selectin. Biochim. Biophys. Acta 1789, 146–152.
Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan, M.J., and
Carbone, F.R. (1994). T cell receptor antagonist peptides induce positive
selection. Cell 76, 17–27.
Intlekofer, A.M., Banerjee, A., Takemoto, N., Gordon, S.M., Dejong, C.S., Shin,
H., Hunter, C.A., Wherry, E.J., Lindsten, T., and Reiner, S.L. (2008). Anomalous
type 17 response to viral infection by CD8+ T cells lacking T-bet and eomeso-
dermin. Science 321, 408–411.
Kuo, C.T., Veselits, M.L., Barton, K.P., Lu, M.M., Clendenin, C., and Leiden,
J.M. (1997a). The LKLF transcription factor is required for normal tunica media
formation and blood vessel stabilization during murine embryogenesis. Genes
Dev. 11, 2996–3006.
Kuo, C.T., Veselits, M.L., and Leiden, J.M. (1997b). LKLF: A transcriptional
regulator of single-positive T cell quiescence and survival. Science 277,
1986–1990.
Lee, J.S., Yu, Q., Shin, J.T., Sebzda, E., Bertozzi, C., Chen, M., Mericko, P.,
Stadtfeld, M., Zhou, D., Cheng, L., et al. (2006). Klf2 is an essential regulator
of vascular hemodynamic forces in vivo. Dev. Cell 11, 845–857.
Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W.,
Perez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., et al.
(2001). A critical role for Dnmt1 and DNA methylation in T cell development,
function, and survival. Immunity 15, 763–774.
Lo, C.G., Xu, Y., Proia, R.L., and Cyster, J.G. (2005). Cyclical modulation of
sphingosine-1-phosphate receptor 1 surface expression during lymphocyte
recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201,
291–301.
Lord, G.M., Rao, R.M., Choe, H., Sullivan, B.M., Lichtman, A.H., Luscinskas,
F.W., and Glimcher, L.H. (2005). T-bet is required for optimal proinflammatory
CD4+ T-cell trafficking. Blood 106, 3432–3439.
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J.,
Thornton, R., Shei, G.J., Card, D., Keohane, C., et al. (2002). Alteration ofImmunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc. 129
Immunity
KLF2 Restrains Naive T Cell Identitylymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Science 296, 346–349.
Matloubian, M., Lo, C.G., Cinamon, G., Lesneski, M.J., Xu, Y., Brinkmann, V.,
Allende, M.L., Proia, R.L., and Cyster, J.G. (2004). Lymphocyte egress from
thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Nature 427, 355–360.
McCaughtry, T.M.,Wilken, M.S., and Hogquist, K.A. (2007). Thymic emigration
revisited. J. Exp. Med. 204, 2513–2520.
Ohara, J., and Paul, W.E. (1988). Up-regulation of interleukin 4/B-cell stimula-
tory factor 1 receptor expression. Proc. Natl. Acad. Sci. USA 85, 8221–8225.
Pearson, R., Fleetwood, J., Eaton, S., Crossley, M., and Bao, S. (2008). Krup-
pel-like transcription factors: A functional family. Int. J. Biochem. Cell Biol. 40,
1996–2001.
Ramalingam, T.R., Pesce, J.T., Sheikh, F., Cheever, A.W., Mentink-Kane,
M.M., Wilson, M.S., Stevens, S., Valenzuela, D.M., Murphy, A.J., Yancopou-
los, G.D., et al. (2008). Unique functions of the type II interleukin 4 receptor
identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat. Immu-
nol. 9, 25–33.
Schnell, F.J., Zoller, A.L., Patel, S.R., Williams, I.R., and Kersh, G.J. (2006).
Early growth response gene 1 provides negative feedback to inhibit entry of
progenitor cells into the thymus. J. Immunol. 176, 4740–4747.
Schober, S.L., Kuo, C.T., Schluns, K.S., Lefrancois, L., Leiden, J.M., and
Jameson, S.C. (1999). Expression of the transcription factor lung Kruppel-
like factor is regulated by cytokines and correlates with survival of memory
T cells in vitro and in vivo. J. Immunol. 163, 3662–3667.130 Immunity 31, 122–130, July 17, 2009 ª2009 Elsevier Inc.Sebzda, E., Zou, Z., Lee, J.S., Wang, T., and Kahn, M.L. (2008). Transcription
factor KLF2 regulates the migration of naive T cells by restricting chemokine
receptor expression patterns. Nat. Immunol. 9, 292–300.
Shiow, L.R., Rosen, D.B., Brdickova, N., Xu, Y., An, J., Lanier, L.L., Cyster,
J.G., and Matloubian, M. (2006). CD69 acts downstream of interferon-alpha/
beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature
440, 540–544.
Smiley, S.T., Kaplan, M.H., and Grusby, M.J. (1997). Immunoglobulin E
production in the absence of interleukin-4-secreting CD1-dependent cells.
Science 275, 977–979.
Snapper, C.M., and Paul,W.E. (1987). Interferon-gamma and B cell stimulatory
factor-1 reciprocally regulate Ig isotype production. Science 236, 944–947.
Stadtfeld, M., and Graf, T. (2005). Assessing the role of hematopoietic plas-
ticity for endothelial and hepatocyte development by non-invasive lineage
tracing. Development 132, 203–213.
Takemoto, N., Intlekofer, A.M., Northrup, J.T., Wherry, E.J., and Reiner, S.L.
(2006). Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin
expression during pathogen-induced CD8+ T cell differentiation. J. Immunol.
177, 7515–7519.
Whyatt, D., and Grosveld, F. (2002). Cell-nonautonomous function of the
retinoblastoma tumour suppressor protein: new interpretations of old pheno-
types. EMBO Rep. 3, 130–135.
Zhu, J., and Paul, W.E. (2008). CD4 T cells: fates, functions, and faults. Blood
112, 1557–1569.
